Home-based unsupervised pulmonary rehabilitation program improves the respiratory disability in systemic sclerosis patients with dyspnea: an observational prospective study.


Journal

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
ISSN: 1122-0643
Titre abrégé: Monaldi Arch Chest Dis
Pays: Italy
ID NLM: 9307314

Informations de publication

Date de publication:
28 Dec 2021
Historique:
received: 21 06 2021
accepted: 17 12 2021
pubmed: 30 12 2021
medline: 29 6 2022
entrez: 29 12 2021
Statut: epublish

Résumé

Dyspnea is a common symptom in Systemic Sclerosis (SSc) that considerably decreases patients' quality of life (QoL). Pulmonary Rehabilitation (PR) mitigates dyspnea impact on daily activities. The aim of this study is to evaluate the effect on respiratory disability of home-based PR in SSc patients with dyspnea. In this observational prospective monocentric study, we screened all dyspneic SSc consecutive patients attending the Rheumatological day hospital in the University hospital of Parma from January 2019 and June 2019. The aim of our study was to understand if a PR unsupervised home-based program could improve respiratory disability in this specific population. Dyspnea was evaluated with the self-administered questionnaires modified Medical Research Council (mMRC) and  Saint George's Respiratory Questionnaire (SGRQ).Patients also filled in Short Form 36 (SF36) and the Modified-Health Assessment Questionnaire for SSc (HAQ-MOD). Health Professionals assessed and trained the patients and collected data before PR and at the end of the program. PR consisted in 5 weekly unsupervised sessions for 8 weeks. Wilcoxon test for paired data evaluated the changes after PR. p<0.05 was considered statistically significant. 46 SSc patients were included (43 female). Only 31 (29 female) performed PR as planned (Adherent Group-AG) while the others gave up within the first week (Non-Adherent Group-NAG). All SGRQ domains (Symptoms: from 30 to 18; p=0.0055; Activity: from 47 to 35, p=0.23; Impact from 29 to 25, p=0.044) and SGRQ total score (from 35 to 29; p=0.022) improved in AG. SGRQ scores did not change in NAG as well as SF36 and HAQ-MOD in both groups. The home-based PR program dramatically decreased the effect, frequency and severity of respiratory symptoms. Conversely, it slightly changed the activities causing breathlessness and dyspnea-related social functioning disturbances. PR appears to be a useful tool in treatment strategies aiming to achieve a QoL improvement in SSc patients.

Identifiants

pubmed: 34964573
doi: 10.4081/monaldi.2021.1984
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Silvia Faverzani (S)

University Hospital of Parma. silvia.faverzani@unipr.it.

Filippo Nocera (F)

Department of Medicine, Internal Medicine and Rheumatology Unit, University Hospital of Parma. Filippo.Nocera86@gmail.com.

Ernesto Crisafulli (E)

Department of Medicine, Respiratory Medicine Unit, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona. ernesto.crisafulli@univr.it.

Maurizio Marvisi (M)

Internal Medicine Unit, Figlie di San Camillo Hospital, Cremona. mmarvis@alice.it.

Andrea Becciolini (A)

Department of Medicine, Internal Medicine and Rheumatology Unit, University Hospital of Parma. beccio@yahoo.it.

Federica Mosetti (F)

University Hospital of Parma. silvia.faverzani@unipr.it.

Eleonora Di Donato (E)

Department of Medicine, Internal Medicine and Rheumatology Unit, University Hospital of Parma. eldidonato@ao.pr.it.

Flavio Mozzani (F)

Department of Medicine, Internal Medicine and Rheumatology Unit, University Hospital of Parma. fmozzani@ao.pr.it.

Daniele Santilli (D)

Department of Medicine, Internal Medicine and Rheumatology Unit, University Hospital of Parma. dsantilli@ao.pr.it.

Giuseppe Scopelliti (G)

Cystic Fibrosis Unit, Azienda Ospedaliero Universitaria di Ancona. scopelliti27@yahoo.it.

Alarico Ariani (A)

Department of Medicine, Internal Medicine and Rheumatology Unit, University Hospital of Parma. aariani@ao.pr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH